Biotech
Heart Drug Trial Misses Its Goal
A new medicine from Novartis did not help patients avoid heart attacks or strokes in a recent big study.
Many people hoped a new drug could protect hearts. The drug, made by Novartis, aimed to lower a bad protein called Lp(a). This protein can raise the chance of heart disease. Doctors watched this study closely.
The study looked at many patients. It checked if the drug could stop heart attacks, strokes, or other major heart problems. The results are now in. The drug did not lower these risks. This is a big setback.
This news means we still need new ways to fight Lp(a). Scientists continue to look for drugs that can help. Novartis will keep working on heart health. They want to find treatments that truly protect people.
Source: FierceBiotech
#Biotech#Novartis#Heart Health#Drug Trial
More from Biotech
